I think Fulgent Genetics is extremely cheap and institutional investors are just barely starting to take notice. The near term catalysts for massive upside are already in play and not priced into the stock.
I am still a believer in the long term prospects for this company. I took profits because I think it may come under selling pressure when the convertible note converts to common stock. Something that will take place over the next couple weeks.
// ---> Here is a paragraph from yesterdays share holder notice:
The Company’s expected use of proceeds from the Notes...
If you followed my prior videos you bought this trade early in this cycle. I still think some strategic moves are in play. In either case plan to hold through $8 and evaluate the technical situation then.
I know this space. In my opinion VRM is ready to rally. If you believe in parity Carvana should be cheaper and Vroom should be more valuable.
Related symbol of interest is SFT (Shift Technologies) I think either VRM or CVNA could end up buying shift. That said Vroom is a lot bigger and I like the stock set-up for a nice rip.